Nolpaza (Pantoprazole)

Pantoprazole, the active ingredient in Nolpaza, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal conditions. GNH USA supplies Nolpaza as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nolpaza, a proton pump inhibitor, is indicated for several acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates reflux symptoms and promotes healing of the esophageal lining. - Erosive oesophagitis: reduces acid exposure to allow ulcer healing. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors. - Prevention of NSAID‑induced gastric ulcers: protects the stomach lining in patients receiving non‑steroidal anti‑inflammatory drugs.

Adverse reactions may occur with any medication.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated diarrhea - Low magnesium levels (hypomagnesemia)

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in patients with severe impairment. - Monitor for signs of infection: especially Clostridioides difficile colitis. - Use cautiously in patients with hepatic disease. - Avoid concomitant use with drugs that require an acidic environment for absorption. - Store at room temperature: keep in the original container, protect from moisture.

Pantoprazole may affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy. - Atazanavir: decreased antiviral activity. - Clopidogrel: diminished activation and antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: potential rise in serum levels. - Methotrexate: risk of increased toxicity.